Breast Cancer Treatment

LETROZOLE (BD-LETRO) 2.5MG Tablet

$99.00

Letrozole BD-LETRO 2.5mg Tablet represents a cornerstone in the management of hormone receptor-positive breast cancer, offering a targeted and effective therapeutic option to improve patient outcomes. By inhibiting estrogen production and estrogen-driven tumor growth, Letrozole plays a crucial role in reducing the risk of cancer recurrence and controlling disease progression in both early-stage and advanced breast cancer.

Quantity

LETROZOLE (BD-LETRO) 2.5MG Tablet quantity

Add to cart

Tag:

LETROZOLE BD-LETRO

Description

BD-LETRO is a medication containing Letrozole, primarily used to treat breast cancer in postmenopausal women. It belongs to the class of drugs known as aromatase inhibitors, which work by decreasing the amount of estrogen produced in the body, thereby slowing or stopping the growth of cancer cells.

Key Features:

• Breast Cancer Treatment: Letrozole is prescribed for the treatment of hormone receptor-positive breast cancer, either alone or in combination with other therapies.
• Postmenopausal Women: It is specifically indicated for use in postmenopausal women, as estrogen production is significantly reduced after menopause.
• Aromatase Inhibitor: Letrozole inhibits the enzyme aromatase, which converts androgens into estrogens, thereby reducing estrogen levels in the body.
• Oral Tablet: BD-LETRO is available in tablet form for oral administration, making it convenient for daily use.
• Effective Therapy: Clinical studies have shown Letrozole to be effective in reducing the risk of breast cancer recurrence and improving overall survival rates in postmenopausal women.